Inovio Pharmaceuticals
INO
INO
133 hedge funds and large institutions have $32.1M invested in Inovio Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 26 increasing their positions, 44 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 63
68% less capital invested
Capital invested by funds: $99.8M → $32.1M (-$67.7M)
Holders
133
Holding in Top 10
–
Calls
$274K
Puts
$12K
Top Buyers
| 1 | +$2.38M | |
| 2 | +$1.25M | |
| 3 | +$1.01M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$805K |
| 5 |
Two Sigma Investments
New York
|
+$803K |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$7.65M | |
| 3 | -$2.17M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.78M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.27M |